Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: Relationship with tumor dissemination and prognostic importance

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 35-40

  Terol, María José ^a   López Guillermo, Armando ^a   Bosch, Francesc ^a   Villamor, Neus ^a   Cid, María Cinta ^a   Rozman, Ciril ^a   Campo, Elías ^a   Montserrat, Emilio ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0344193112     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.35     Document Type: Article

References (34)

1. Malgoba MW, Sanders ME, Ginther Luce GE, et al: ICAM-1: A ligand for LFA-1 dependent adhesion of B, T and myeloid cells. Nature 331:86-88, 1988
2. Maio M, Del Vecchio L: Expression and functional role of CD54/intercellular adhesion molecule-1 (ICAM-1) on human blood cells. Leuk Lymph 8:23-33, 1992
3. Boyd AW, Wawryk SO, Burns GF, et al: Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA 93:3095-3099, 1988
4. Wawryk SO, Novotny JR, Wicks IP, et al: The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev 108:135-161, 1989
5. Gregory CD, Murray RJ, Edwards CF, et al: Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 167:1811-1824, 1988
6. Stauder R, Greil R, Schulz TF, et al: Expression of leukocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin's lymphomas and leukemias: Possible influence on growth pattern and leukaemic behaviour. Clin Exp Immunol 77:234-238, 1989
7. Cavallo F, Martín-Fontecha A, Bellone M, et al: Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur J Immunol 25:1154-1162, 1995
8. Jansen JH, Van der Harst D, Wientjens GJHM, et al: Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. Blood 80:478-483, 1992
9. Momosaki S, Yano H, Ogasawara S, et al: Expression of intercellular adhesion molecule 1 in human hepatocellular carcinoma. Hepatology 22:1708-1713, 1995
10. Tomita Y, Watanabe H, Kobayashi H, et al: Expression of intercellular adhesion molecule-1 on transitional cell cancer. Am J Pathol 143:191-198, 1993
11. Maio M, Pinto A, Carbone A, et al: Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Blood 76:783-790, 1990
12. Horst E, Radaszkiewicz T, Hooftman-den Otter A, et al: Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia 5:848-853, 1991
13. Boyd AW, Dunn SM, Fecondo JV, et al: Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood 73:1896-1903, 1989
14. Aiello A, Delia D, Fontanella E, et al: Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma. Hematol Oncol 8:229-238, 1990
15. Kimby E, Rincón J, Patarroyo M, et al: Expression of adhesion molecules CD11/CD18 (Leu-CAMS, beta2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia. Leuk Lymph 13:297-306, 1994
16. Horst E, Meijer CJLM, Radaszkiewicz T, et al: Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595-599, 1990
17. Christiansen I, Gidlöf C, Wallgren AC, et al: Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocyte leukemia and correlate with clinical stage and prognostic markers. Blood 84:3010-3016, 1994
18. Molica S, Dattilo A, Mannella A, et al: Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: Implications for prognosis. Leuk Res 19:573-580, 1995
19. Christiansen I, Enblad G, Kälkner KM, et al: Soluble ICAM-1 in Hodgkin's disease: A promising independent predictive marker for survival. Leuk Lymph 19:243-251, 1995
20. Cabanillas F, McIntyre B, Lee MS, et al: Serum level of surface molecules (SM) predicts outcome in low grade lymphoma (LGL): A stage independent predictive system with a biological basis. Proc Am Soc Clin Oncol 14:388, 1995 (abstr)
21. Christiansen I, Gidlöf C, Kälkner KM, et al: Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers. Br J Haematol 92:639-646, 1996
22. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
23. Engel P, Serra C, Acevedo G, et al: Implication de CD18 y CD54 en la reacción linfocitaria mixta frente a linfocitos B CD5+ leucémicos. Inmunología 11:21-31, 1992
24. Kaplan GL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. 2/E in the log-rank test for survival data or tumour incidence data. Biometrics 29:759-784, 1973
26. Cox DR: Regression model and life tables. J R Stat Assoc 34:187-220, 1972
27. Dixon WJ, Brown MB, Engelman L, et al: BMDP Statistical Software, Berkeley, CA, University of California, 1988, pp 719-743
28. The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
29. Springer TA: Adhesion receptors of the immune system. Nature 346:425-433, 1990
30. Makgoba MW, Sanders ME, Shaw S: The CD2-LFA-3 and LFA-1-ICAM pathways: Relevance to T-cell recognition. Immunol Today 10:417-422, 1989
31. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigma. Cell 76:301-314, 1994
32. van Seventer GA, Shimizu Y, Shaw S: Roles of multiple accessory molecules in T-cell activation. Curr Opin Immunol 3:294-303, 1991
33. Takeshita M, Akamatsu M, Ohsima K, et al: CD30 (Ki-1) expression in adult T-cell leukaemia/lymphoma is associated with distinctive immunohistological and clinical characteristics. Histopathology 26:539-546, 1995
34. Vacca A, Ranieri G, Ribatti D, et al: Differential expression of two ICAM-1 epitopes and LFA-1 chains in B-cell non-Hodgkin's lymphomas. Eur J Haematol 53:85-92, 1994